OBJECTIVES: To examine the safety, efficacy, and tolerability of tolterodine in four randomized,
double-blind, parallel, multicenter, 12-week studies of patients with overactive bladder. …

Objectives. To describe the rationale for the use of electrical stimulation (ES) for the treatment
of urinary incontinence, and to summarize the results of clinical studies assessing these …

… Author links open overlay panel Rodney A. Appell MD a 1 , Peter Sand MD b , Roger …
Dr Appell is an adviser, investigator, and speaker for ALZA Corporation and a speaker and …

The goal of treatment in patients with ISD is to allow for coaptation of the urethral mucosa
without obstruction. Urodynamically this means that the pressure necessary to open the urethra …

Purpose : We updated the 1997 American Urological Association guideline on female
stress incontinence. Materials and Methods : MEDLINE® searches of English language …

… Before extended-release tolterodine was FDA-approved, Appell et al 15 compared 10 mg of
once-daily extended-release oxybutynin to 2 mg of twice-daily immediate-release tolterodine…

1. Purpose—The purpose of this document is to provide minimal standards by which the
efficacy of therapy for urinary incontinence may be assessed. The standards were developed by …

Objectives. To report the first data from a prospective clinical study to determine the feasibility
of using extracorporeal magnetic innervation (ExMI) for the treatment of stress urinary …

1. Purpose—The purpose of this document is to provide a uniform lexicon for describing
urinary incontinence. This lexicon was developed by a committee of the Urodynamic Society …

Due to the large variability in the reported contribution of bladder dysfunction to postprostatectomy
incontinence and the impact this dysfunction may have on the outcome of selected …